Cardioplegia solution is used to arrest the cardiac activity during cardiopulmonay bypass.
Types-
ST Thomas I (Maccarthy)
- Nacl-144mmol/l
- Kcl -20mmol/l
- Mgcl -16
- Cacl2 -2.4 meq/l
- NaHco3-
- Procaine-1.0
- pH – 5.5-7.0
- osmolarity -300-320
ST Thomas II (Plegisol)
- Nacl -110
- Kcl -16
- Mgcl -16
- Cacl2-1.2
- NaHco3 -10
- pH- 7.8
- osmolarity -285-300
MYOCARDIAL PROTECTION STRATEGIES
- Anaesthetic agents
- Nanovolemic hemodilution
- Non cardioplegia medication
- Neutrophil depletion
- Ischaemic preconditioning
- Offpump revascularization
CARDIOPLEGIA DELIVERY SYSTEM
SrNo | PROS | CONS | |
1 | Antegrade | simple,mimics normal flow | Requires competent aortic valve, advanced CAD |
2 | Retrograde | obviates limitations form Aortic insufficiency And CAD, Does not improve
Conduict of surgery , augments dearing |
Catheter placement can be difficult. Complex |
3 | Throng conduits | Allows antegrade protection of
Areas of CAD , obviates limitation from AR and CAD Allows, need to pressure aortic root too or interrupt surgery |
Requires conduit ,
right coronary distribution poor , complex |
4 | integreated | maintain uniform distribution of cardioplegia | Complexity |
5 | Blood | Provides substrate for metabolic demands of myocardium.High colloid oncotic pressure increase.
Avoid cellular edema. Oxygen carrying capacity, Buffering action,Similar in electrolyte. Compositiom and osmolarity Free radical scavenging ability |
Cost,Complexity ,
Viscosity Left shift of O2 curve
High O2 and substrate Not required. |
6 | CRYSTALLOID | Inexpensive , simplicity , availability | large volume of crystalloid, No buffering , No O2 carrying capacity |
7 | MICROPLAGIA | Large volume of cardioplegia but minimum crystalloid volume According to quantification of quadriplegia delivery |
cost , complexity |
Ability to further modify cardioplegia with additives
ADDITIVE | FUNCTION | |
1 | K+ / Mg+/procaine | immediate arrest |
2 | Hypothermia 10-20 degree celcius | decrease metabolism |
3 | Glucose | as substrate for metabolism |
4 | O2/blood | substrate |
5 | Glutamate / asparatate | substrate |
6 | Hco3/THAM/Phosphate | buffer |
7 | FFP/Albumin | colloid osmotic pressure increases and decreases oedema. |
8 | Methylprednisolone | decreases edema |
Delivery schedule
Pros | Cons |
1.Intermittant- improved exposure,Low cardioplegia solution | increase in interval in dosing causes my-ocardial acidosis |
2.Continuous- Normal perfusion | operative field disturbances. |
Increase post op LV Function,Decrease ionotropic support post op | complexity of delivery, |
ADDITIVES:
Nicorandil: Adenosine triphosphate sensitive K+ channels opener
Opens K+ channel, cardiacarrest can be achieved with kess toxic doses of K+ containing cardioplegia
Preconditioning agent
PROS | CONS | |
Nicorandil | less cardioplegia and K+requirement
Reduced peri operative Coronary spasm Pre conditioning, reduced need for catecholamine use in post op. |
Cost
|
L Arginine | decrease cytokine levels.
decreses myocardial enzyme levels Reduced need for catecholamine use postop Reduced pulomary wedge pressure. |
Cost
complexity |
Insulin | Increases survival and improved lt.ventriculat function. | Complexity,
efficacy not clear.
|
NON CARDIOPLEGIA MEDICATIONS:
- Erythropoeitin: protect for hypoxia and oxidative stress
- N-acetyl cysteine : reactive O2 scavenger
- Deferoxamine: iron chelator
PROS | CONS | |
Anaesthetic Agents | Provide pre conditioning | unclear |
Acute Normovolemic haemodilution | Less myocardial injury
Cpk-mb release and decreased Ionotrope requirement Reduced incidence of atrial fibrillation and conduction block. |
efficacy not clear
anaemia |
Neutrophil depletion | decrease post bypass VF
Lower ionotropic use and post op cardiac enzyme |
Cost
Compliance |
Erythropoeitin | limits myocardial injury | Cost |
N-acetyl cysteine | may reduce ocidative stress | Cost |
Deferoxamine | decrease lipid peroxidation
Increase myocardial protection Decrease post op wall motion abnormalities |
Cost |
Statins | increase NO release
Anti oxidative properties |
dr.ajita.